Skip to main content
. 2020 Nov 20;10:595838. doi: 10.3389/fonc.2020.595838

Figure 2.

Figure 2

(A) Overall survival (OS) of the 68 patients [all myelodysplastic syndromes (MDS) subtypes]; relative expression (RE) levels of miR-21 (B), miR-181a (C), miR-155 (D) and OS.